GenPharm International Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
GenPharm International General Information
Description
Developer of fully human monoclonal antibodies based on transgenic animal technology. The company also produces HuMAb-Mouse (tm) transgenic system for the production of fully human MAbs. The company applies transgenic animal technology to the development of human antibody products for therapeutic uses.
Contact Information
Website
www.genpharm.comCorporate Office
- 855 California Avenue
- Palo Alto, CA 94304
- United States
Corporate Office
- 855 California Avenue
- Palo Alto, CA 94304
- United States
GenPharm International Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Oct-1997 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Startup |
GenPharm International Patents
GenPharm International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2005276787-A1 | Binding member towards pneumolysin | Inactive | 23-Aug-2004 | ||
| EP-1791867-A2 | Binding member towards pneumolysin | Inactive | 23-Aug-2004 | ||
| US-20090214547-A1 | Binding member towards pneumolysin | Inactive | 23-Aug-2004 | ||
| EP-1646654-A1 | Binding member towards pneumococcus surface adhesin a protein (psaa) | Inactive | 08-Jul-2003 | ||
| US-20070003561-A1 | Binding member towards pneumococcus surface adhesin a protein (psaa) | Inactive | 08-Jul-2003 | C07K16/1275 |
GenPharm International Former Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| Avalon Ventures | Venture Capital | Minority | ||
| Charterhouse Capital Partners | PE/Buyout | Minority | ||
| Collagen Corporation | Corporation | Minority |
GenPharm International FAQs
-
When was GenPharm International founded?
GenPharm International was founded in 1989.
-
Where is GenPharm International headquartered?
GenPharm International is headquartered in Palo Alto, CA.
-
What industry is GenPharm International in?
GenPharm International’s primary industry is Biotechnology.
-
Is GenPharm International a private or public company?
GenPharm International is a Private company.
-
What is GenPharm International’s current revenue?
The current revenue for GenPharm International is .
-
Who are GenPharm International’s investors?
Abingworth, Atlas Venture, Avalon Ventures, Charterhouse Capital Partners, and Collagen Corporation are 5 of 20 investors who have invested in GenPharm International.
-
When was GenPharm International acquired?
GenPharm International was acquired on 01-Oct-1997.
-
Who acquired GenPharm International?
GenPharm International was acquired by Medarex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process